loading...| Preferred Name |
Physostigmine |
|
| Synonyms |
Pyrrolo(2,3-b)indol-5-ol, 1,2,3,3a,8,8a-hexahydro-1,3a,8-trimethyl-, methylcarbamate (ester), (3aS-c |
|
| Definitions |
A cholinesterase inhibitor that is rapidly absorbed through membranes. It can be applied topically to the conjunctiva. It also can cross the blood-brain barrier and is used when central nervous system effects are desired, as in the treatment of severe anticholinergic toxicity. (source : MSH) |
|
| ID |
http://doe-generated-ontology.com/OntoAD#C0031849 |
|
| altLabel |
Pyrrolo(2,3-b)indol-5-ol, 1,2,3,3a,8,8a-hexahydro-1,3a,8-trimethyl-, methylcarbamate (ester), (3aS-c ésérine physostigmines |
|
| contraindicated_drug |
http://doe-generated-ontology.com/OntoAD#C0013182 |
|
| definition |
A cholinesterase inhibitor that is rapidly absorbed through membranes. It can be applied topically to the conjunctiva. It also can cross the blood-brain barrier and is used when central nervous system effects are desired, as in the treatment of severe anticholinergic toxicity. (source : MSH) |
|
| hiddenLabel |
Physostigmine Physostigmine |
|
| may_treat | ||
| prefixIRI |
OntoAD:C0031849 |
|
| prefLabel |
Physostigmine Physostigmine |
|
| subClassOf |
http://doe-generated-ontology.com/OntoAD#C0304408 |